Literature DB >> 8844208

Mutation pattern in clinically asymptomatic coagulation factor VII deficiency.

F Bernardi1, G Castaman, M Pinotti, P Ferraresi, M G Di Iasio, B Lunghi, F Rodeghiero, G Marchetti.   

Abstract

A total of 122 subjects, referred after presurgery screening or checkup for prolonged prothrombin time, were characterized for the presence of coagulation factor VII deficiency. Fourteen subjects carried a partial and asymptomatic deficiency, and in half of them dysfunctional molecules were detected in plasma. In nine subjects we found five missense mutations differing from those previously found in factor VII deficient patients. The others were homozygous for a common polymorphism (R353Q) that affects factor VII levels. A new codon dimorphism (A330) was also found in exon 8. Four mutations (R223W, M298I, R304Q, and R353Q) located at FVII-specific residues point out protein regions that are important for coagulation factor evolution, and two mutations (G342E and E265K) affect generic or partially generic residues. The newly reported mutations were combined with those we previously found, totalling 17 independent mutations responsible for FVII deficiency in 27 Italian pedigrees. We observed several similarities with the mutation pattern determined in factor IX, which include a high percentage of transitions at CpG doublets, the presence of hot spot sites affected by multiple substitutions, and of several topologically equivalent mutations.

Entities:  

Mesh:

Year:  1996        PMID: 8844208     DOI: 10.1002/(SICI)1098-1004(1996)8:2<108::AID-HUMU2>3.0.CO;2-7

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  6 in total

Review 1.  Associated prothrombotic conditions are probably responsible for the occurrence of thrombosis in almost all patients with congenital FVII deficiency. Critical review of the literature.

Authors:  A Girolami; F Tezza; R Scandellari; S Vettore; B Girolami
Journal:  J Thromb Thrombolysis       Date:  2010-08       Impact factor: 2.300

2.  Functional role of residue 193 (chymotrypsin numbering) in serine proteases: influence of side chain length and beta-branching on the catalytic activity of blood coagulation factor XIa.

Authors:  Amy E Schmidt; Mao-fu Sun; Taketoshi Ogawa; S Paul Bajaj; David Gailani
Journal:  Biochemistry       Date:  2008-01-11       Impact factor: 3.162

3.  Identification of two novel mutations in three children with congenital factor VII deficiency.

Authors:  Kairong Liang; Lauriane Nikuze; Fuyong Zhang; Zhengjing Lu; Manlv Wei; Hongying Wei
Journal:  Blood Coagul Fibrinolysis       Date:  2021-07-01       Impact factor: 1.061

Review 4.  Factor VII Deficiency: Clinical Phenotype, Genotype and Therapy.

Authors:  Mariasanta Napolitano; Sergio Siragusa; Guglielmo Mariani
Journal:  J Clin Med       Date:  2017-03-28       Impact factor: 4.241

Review 5.  Biochemical, molecular and clinical aspects of coagulation factor VII and its role in hemostasis and thrombosis.

Authors:  Francesco Bernardi; Guglielmo Mariani
Journal:  Haematologica       Date:  2021-02-01       Impact factor: 9.941

6.  Identification of genetic defects underlying FVII deficiency in 10 patients belonging to eight unrelated families of the North provinces from Tunisia.

Authors:  Hejer Elmahmoudi; Fatma Ben-Lakhal; Wijden Elborji; Asma Jlizi; Kaouther Zahra; Rim Sassi; Moez Zorgan; Balkis Meddeb; Amel Elgaaied Ben Ammar; Emna Gouider
Journal:  Diagn Pathol       Date:  2012-08-08       Impact factor: 2.644

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.